GREAT POINT PARTNERS LLC
Filing Date
Global Rank
#2,828
/ 8,605
▲ 748
· as of Mar 2026
Top Industry
Biotechnology
83.1%
3Y Alpha vs SPY
+14.6%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+122.4%
SPY
+76.5%
Annualised alpha
+9.7%
Max drawdown
−61.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
42 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.5%
+1.7 pts
Top 5
34.6%
−2.9 pts
Top 10
55.8%
−7.4 pts
HHI
439
Diversified−74
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $483,611,456 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ZURA | Zura Bio Ltd | +400,000 | 4,215,930 | $25,084,783 | |
| VOR | Vor Biopharma Inc. | +379,893 | 1,750,000 | $31,220,000 | |
| CLYM | Climb Bio, Inc. | +354,596 | 1,334,130 | $9,138,790 | |
| SLN | Silence Therapeutics plc | +212,457 | 1,020,489 | $5,377,977 | |
| JBIO | Jade Biosciences, Inc. | +158,189 | 964,462 | $13,550,691 | |
| NGNE | Neurogene Inc. | +150,000 | 500,000 | $10,080,000 | |
| NKTR | Nektar Therapeutics | +105,721 | 316,453 | $22,768,793 | |
| CTNM | Contineum Therapeutics, Inc. | +198 | 800,198 | $10,450,585 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | −2,445,215 | 2,238,496 | $5,864,859 | |
| CGEM | Cullinan Therapeutics, Inc. | −334,032 | 300,000 | $4,263,000 | |
| IMVT | Immunovant, Inc. | −204,375 | 545,625 | $13,553,325 | |
| KALV | KalVista Pharmaceuticals, Inc. | −10,632 | 675,000 | $13,587,750 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
21 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SCYX | Scynexis Inc | 7,554,347 | $55,418,689 | |
| IBRX | ImmunityBio, Inc. | 3,000,800 | $23,016,136 | |
| SLGL | Sol-Gel Technologies Ltd. | 274,363 | $21,735,036 | |
| ALMS | Alumis Inc. | 856,061 | $18,859,023 | |
| DRUG | Bright Minds Biosciences Inc. | 220,000 | $16,053,400 | |
| ANNX | Annexon, Inc. | 2,500,000 | $13,850,000 | |
| ZBIO | Zenas BioPharma, Inc. | 524,066 | $10,245,490 | |
| MLTX | MoonLake Immunotherapeutics | 500,000 | $9,320,000 | |
| VERA | Vera Therapeutics, Inc. | 199,348 | $8,019,770 | |
| LBRX | Lb Pharmaceuticals Inc | 300,000 | $7,398,000 | |
| CMPX | Compass Therapeutics, Inc. | 1,350,000 | $7,141,500 | |
| PALI | Palisade Bio, Inc. | 3,405,757 | $5,960,074 | |
| RLMD | Relmada Therapeutics, Inc. | 842,106 | $5,861,057 | |
| TENX | Tenax Therapeutics, Inc. | 327,307 | $5,233,638 | |
| PMN | ProMIS Neurosciences Inc. | 371,402 | $4,716,805 | |
| IMMX | Immix Biopharma, Inc. | 350,000 | $3,188,500 | |
| HUMA | Humacyte, Inc. | 3,750,000 | $2,276,250 | |
| GALT | Galectin Therapeutics Inc | 800,000 | $2,232,000 | |
| ALKS | Alkermes plc. | 50,000 | $1,768,000 | |
| AVXL | Anavex Life Sciences Corp. | 521,300 | $1,600,391 | |
| IRD | Opus Genetics, Inc. | 324,340 | $1,475,747 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IRON | Disc Medicine, Inc. | 250,000 | $19,852,500 | |
| SLNO | Soleno Therapeutics Inc | 400,000 | $18,520,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 350,000 | $14,423,500 | |
| FULC | Fulcrum Therapeutics, Inc. | 800,000 | $9,048,000 | |
| UPB | Upstream Bio, Inc. | 300,000 | $8,145,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 300,000 | $6,900,000 | |
| SANA | Sana Biotechnology, Inc. | 700,000 | $2,849,000 | |
| No positions match the current search. | ||||
42 positions ·
$483,611,456 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SCYX |
Scynexis Inc
Healthcare
|
NEW | 7,554,347 | $55,418,689 | 11.46% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Held | 374,000 | $31,479,580 | 6.51% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Added | 1,750,000 | $31,220,000 | 6.46% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 4,215,930 | $25,084,783 | 5.19% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Held | 1,750,000 | $24,325,000 | 5.03% | |
| IBRX |
ImmunityBio, Inc.
Healthcare
|
NEW | 3,000,800 | $23,016,136 | 4.76% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 316,453 | $22,768,793 | 4.71% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
NEW | 274,363 | $21,735,036 | 4.49% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 856,061 | $18,859,023 | 3.90% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
NEW | 220,000 | $16,053,400 | 3.32% | |
| ANNX |
Annexon, Inc.
Healthcare
|
NEW | 2,500,000 | $13,850,000 | 2.86% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Reduced | 675,000 | $13,587,750 | 2.81% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 545,625 | $13,553,325 | 2.80% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Added | 964,462 | $13,550,691 | 2.80% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Added | 800,198 | $10,450,585 | 2.16% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
NEW | 524,066 | $10,245,490 | 2.12% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Added | 500,000 | $10,080,000 | 2.08% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 500,000 | $9,320,000 | 1.93% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Added | 1,334,130 | $9,138,790 | 1.89% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Held | 183,330 | $8,992,336 | 1.86% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Held | 1,200,000 | $8,688,000 | 1.80% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
NEW | 199,348 | $8,019,770 | 1.66% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 325,000 | $7,471,750 | 1.54% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
NEW | 300,000 | $7,398,000 | 1.53% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
NEW | 1,350,000 | $7,141,500 | 1.48% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
NEW | 3,405,757 | $5,960,074 | 1.23% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Reduced | 2,238,496 | $5,864,859 | 1.21% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 842,106 | $5,861,057 | 1.21% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Added | 1,020,489 | $5,377,977 | 1.11% | |
| UNCY |
Unicycive Therapeutics, Inc.
Healthcare
|
Held | 796,558 | $5,241,351 | 1.08% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
NEW | 327,307 | $5,233,638 | 1.08% | |
| PMN |
ProMIS Neurosciences Inc.
Healthcare
|
NEW | 371,402 | $4,716,805 | 0.98% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Reduced | 300,000 | $4,263,000 | 0.88% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
NEW | 350,000 | $3,188,500 | 0.66% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 951,809 | $2,903,017 | 0.60% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 82,800 | $2,339,100 | 0.48% | |
| HUMA |
Humacyte, Inc.
Healthcare
|
NEW | 3,750,000 | $2,276,250 | 0.47% | |
| GALT |
Galectin Therapeutics Inc
Healthcare
|
NEW | 800,000 | $2,232,000 | 0.46% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Held | 124,666 | $1,861,263 | 0.38% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 50,000 | $1,768,000 | 0.37% | |
| AVXL |
Anavex Life Sciences Corp.
Healthcare
|
NEW | 521,300 | $1,600,391 | 0.33% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
NEW | 324,340 | $1,475,747 | 0.31% |